BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
December 16, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Announces Partnership with Kill Cliff FC
December 14, 2022 07:30 ET
|
BioStem Technologies, Inc.
Kill Cliff FC is One of the world’s largest MMA Training Centers with More Than 80 Professional Fighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:...
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
November 15, 2022 16:05 ET
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
September 13, 2022 07:30 ET
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd
August 16, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)
July 15, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 15, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...